DZ Bank Call 30 FRE 21.03.2025/ DE000DJ0S397 /
15/11/2024 13:34:37 | Diferencia0.000 | Bid13:41:13 | Ask13:41:13 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
0.390EUR | 0.00% | 0.400 Volumen de oferta: 150,000 |
0.410 Tamaño/ Volumen/ Formato de Ask: 150,000 |
FRESENIUS SE+CO.KGAA... | 30.00 - | 21/03/2025 | Call |
GlobeNewswire
23/04
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire
23/02
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
04/09/2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
31/08/2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil
GlobeNewswire
24/08/2023
CIO Leadership: The Steps Needed to Build a High-Performance Culture Will Power the Discussion at th...
GlobeNewswire
25/02/2022
Kapruvia® receives positive CHMP opinion for the treatment of moderate-to-severe pruritus in hemodia...
GlobeNewswire
05/01/2022
Oculis appoints Mr. Webb Ding as Global Chief Operating Officer and General Manager (China)
GlobeNewswire
31/12/2021
CIO Leadership: HMG Strategy, the World’s #1 Executive Leadership Network, Looks Ahead to its 15th Y...
GlobeNewswire
09/12/2021
Angion and Vifor Pharma Report Topline Results from Phase 2 GUARD Trial of ANG-3777 in Cardiac Surge...
GlobeNewswire
22/11/2021
Vifor Pharma to acquire Sanifit to further strengthen late-stage pipeline in nephrology
GlobeNewswire
22/11/2021
Vifor Pharma to acquire Sanifit to further strengthen late-stage pipeline in nephrology
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página